Marc Tessier-Lavigne Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Marc Tessier-Lavigne.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Marc Tessier-Lavigne. Marc Tessier-Lavigne is a EVP, RESEARCH DRUG DISCOVERY in GENENTECH INC ($DNA) and a Director in PFIZER INC ($PFE) and a Director in REGENERON PHARMACEUTICALS INC ($REGN) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Juno Therapeutics, Inc. ($JUNO) and a Director in Denali Therapeutics Inc. ($DNLI).

Over the past year Marc Tessier-Lavigne has been an insider in 2 companies. The total value of shares held by Marc Tessier-Lavigne in these companies amounts to $6,019,923.

Marc Tessier-Lavigne Director
AGIOS PHARMACEUTICALS, INC.
Director
Denali Therapeutics Inc.
EVP, RESEARCH DRUG DISCOVERY
GENENTECH INC
Director
Juno Therapeutics, Inc.
Director
PFIZER INC
Director
REGENERON PHARMACEUTICALS, INC.
$ 6019923 The total value of shares held by Marc Tessier-Lavigne
Insider Rank

Marc Tessier-Lavigne ranks 4,613 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 1 DNA WAY SO SAN FRANCISCO 94080 CA

Companies in which Marc Tessier-Lavigne is an Insider

AGIOS PHARMACEUTICALS, INC.

Trading Symbol: AGIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2016
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Denali Therapeutics Inc.

Trading Symbol: DNLI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Tessier-Lavigne: Director
Holdings: 2,739,043 shares
Latest Transaction: Jun 18 2020

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 2x
Shares Bought: 25,000
Shares Sold: 800,000
Share Difference: -775,000
Value Difference: +$20,880,000

GENENTECH INC

Trading Symbol: DNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: EVP, RESEARCH DRUG DISCOVERY
Holdings: 0 shares
Latest Transaction: Mar 30 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Juno Therapeutics, Inc.

Trading Symbol: JUNO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2016
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PFIZER INC

Trading Symbol: PFE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 24 2015
$PFE Market Capitalization: $195.04B
$PFE Previous Close: $32.08

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

REGENERON PHARMACEUTICALS, INC.

Trading Symbol: REGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 16,830 shares
Current Value: $6,019,923
Latest Transaction: May 08 2020
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 5x
Shares Bought: 15,320
Shares Sold: 15,000
Share Difference: +320
Value Difference: +$5,792,196

Latest Insider Trading Transactions of Marc Tessier-Lavigne

Sentiment: All, AGIO, DNLI, DNA, JUNO, PFE, REGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 18 2020DNLIDenali Therapeutic ...Tessier-Lavigne MarcDirectorSellS26.10400,00010,440,0002,739,0433.1 M to 2.7 M (-12.74 %)
Jun 18 2020DNLIDenali Therapeutic ...Tessier-Lavigne MarcDirectorSellS26.10400,00010,440,0002,739,0433.1 M to 2.7 M (-12.74 %)
Jun 05 2020DNLIDenali Therapeutic ...Tessier-Lavigne MarcDirectorOption ExerciseA0.003,25303,253
Jun 05 2020DNLIDenali Therapeutic ...Tessier-Lavigne MarcDirectorOption ExerciseA28.8215,183437,57415,183
May 08 2020REGNREGENERON PHARMACE ...Tessier-Lavigne MarcDirectorOption ExerciseM177.8215,0002,667,3000
May 08 2020REGNREGENERON PHARMACE ...Tessier-Lavigne MarcDirectorSellS566.0110056,6011,8301.9 K to 1.8 K (-5.18 %)
May 08 2020REGNREGENERON PHARMACE ...Tessier-Lavigne MarcDirectorSellS565.35900508,8151,9302.8 K to 1.9 K (-31.80 %)

View all Marc Tessier-Lavigne insider transactions.